Sanara MedTech (SMTI) CEO corrects Form 4 to 414 tax-withheld shares

Rhea-AI Filing Summary

Sanara MedTech Inc. Chief Executive Officer Seth D. Yon filed an amended insider report updating a prior tax-related share withholding. The company withheld 414 shares of common stock at $20.44 per share to cover taxes on the vesting of 1,446 restricted shares, correcting an earlier filing that had shown 491 shares withheld. This was a tax-withholding disposition only, and the filing states that no shares were issued or sold in the transaction. After this adjustment, Yon directly holds 88,564 shares of Sanara MedTech common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Yon Seth D

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	414	$20.44	$8K

Holdings After Transaction: Common Stock — 88,564 shares (Direct)

Footnotes (1)

1. The original Form 4, filed on March 2, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Seth D. Yon (the "Reporting Person"). The original Form 4 mistakenly indicated that the Issuer withheld 491 shares of common stock, when in fact, as reported in this amendment, the Issuer withheld 414 shares of common stock. Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Reporting Person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/09/2026 - 08:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yon Seth D

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TX 76102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F		414(1)(2)	D	$20.44(2)	88,564(1)(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The original Form 4, filed on March 2, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Seth D. Yon (the "Reporting Person"). The original Form 4 mistakenly indicated that the Issuer withheld 491 shares of common stock, when in fact, as reported in this amendment, the Issuer withheld 414 shares of common stock.

2. Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Reporting Person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

	/s/ Seth D. Yon	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Sanara MedTech (SMTI) report for CEO Seth D. Yon?

Sanara MedTech reported that CEO Seth D. Yon had 414 shares of common stock withheld to satisfy tax obligations on the vesting of 1,446 restricted shares. The filing clarifies this was a tax-withholding disposition and that no shares were issued or sold.

Why was the Sanara MedTech (SMTI) Form 4 amended for Seth D. Yon?

The Form 4 was amended to correct the number of shares withheld for taxes. The original report showed 491 shares withheld, but the amendment states the company actually withheld 414 shares of common stock in connection with restricted stock vesting.

Did Sanara MedTech (SMTI) CEO Seth D. Yon sell any shares in this Form 4/A?

No, the filing states that no shares were issued or sold in this transaction. The 414 shares shown were withheld by Sanara MedTech solely to satisfy tax withholding obligations related to the vesting of restricted stock previously granted to Yon.

How many Sanara MedTech (SMTI) shares does Seth D. Yon own after the amendment?

After the tax-withholding disposition, CEO Seth D. Yon directly owns 88,564 shares of Sanara MedTech common stock. This total reflects the corrected number of 414 shares withheld by the company for tax purposes on vested restricted stock.

What price per share was used for the Sanara MedTech (SMTI) tax withholding?

The per-share value assigned to the 414 withheld shares was $20.44. The filing notes this reflects the Nasdaq Capital Market price on the vesting date of the 1,446 restricted shares, which determined the value of the tax-withholding disposition.